Skip to content

A clinical trial to investigate the efficacy of the new fluorescence detection system in fluorescence clip tumor marking for gastric and esophageal malignancies

An exploratory clinical trial to investigate the efficacy of the new fluorescence detection system 'Lumifinder' in fluorescence clip tumor marking for laparoscopic surgery of gastric and esophageal malignancies

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs012240043
Enrollment
25
Registered
2024-10-18
Start date
2025-01-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer, esophago-gastric junction cancer, esophageal cancer gastric cancer, esophago-gastric junction cancer, esophageal cancer

Interventions

Tumor marking with a fluorescent clip under upper gastrointestinal endoscopy preoperatively and exploration of the fluorescent clip using the new fluorescence detection system

Sponsors

Hirano Satoshi
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients aged 18 years or older at the time of obtaining consent 2. Patients scheduled to undergo laparoscopic or thoracoscopic surgery (including robot-assisted surgery) under general anesthesia for the treatment of gastric cancer, esophago-gastric junction cancer, or esophageal cancer 3. Patients who have received sufficient explanation regarding participation in this study, fully understand it, and have given their consent of their own free will

Exclusion criteria

Exclusion criteria: Here is the English translation of the given text: 1. Patients with a history of gastrectomy or esophagectomy. 2. Patients with a history of upper abdominal surgery or other conditions that make them unsuitable for laparoscopic or thoracoscopic surgery. 3. Patients with a metal allergy. 4. Patients deemed unsuitable as research subjects by the principal investigator or co-investigator for other reasons.

Design outcomes

Primary

MeasureTime frame
The feasibility of fluorescent measurement and position identification of Zemex FS Marker using Lumifinder

Secondary

MeasureTime frame
1. Differences in fluorescence intensity due to the location of the lesion and the thickness of either the gastric wall or the esophageal wall 2. Time required for fluorescence measurement and localization 3. Measurement of the oral or anal side margins of the tumor

Contacts

Public ContactHideyuki Wada

Hokkaido University Hospital

hi.hi.de0626@huhp.hokudai.ac.jp+81-11-716-1161

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026